• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

HBM BioVentures

edit

As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures’ portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).

Recent Milestones

edit

• 
  HBM BioVentures invested in PTC Therapeutics. (7/23/12)
  Posted 7/23/12 at 6:11pm via finsmes.com
• 
  HBM BioVentures invested in Probiodrug. (1/4/12)
  Posted 1/4/12 at 8:50pm via finsmes.com
• 
  HBM BioVentures invested in Ellipse Technologies. (8/2/11)
  Posted 8/2/11 at 6:31pm via finsmes.com
• 
  HBM BioVentures invested in Delenex Therapeutics. (5/3/11)
  Posted 5/3/11 at 6:04pm via finsmes.com
• 
  HBM BioVentures invested in Vivacta. (11/18/10)
  Posted 11/18/10 at 6:03pm via finsmes.com
• 
  HBM BioVentures invested in MTM Laboratories. (11/8/10)
  Posted 11/8/10 at 7:27pm via finsmes.com
• 
  HBM BioVentures invested in Cylene Pharmaceuticals. (9/24/10)
  Posted 9/24/10 at 9:49pm via socaltech.com
• 
  HBM BioVentures invested in Nereus Pharmaceuticals. (6/25/10)
  Posted 6/23/10 at 5:27pm via onbiovc.com
• 
  HBM BioVentures invested in Nabriva Therapeutics. (1/17/10)
  Posted 10/28/09 at 6:21pm via onbiovc.com
• 
  HBM BioVentures invested in PTC Therapeutics. (12/22/09)
  Posted 12/22/09 at 3:44pm via finsmes.com
• 
  HBM BioVentures invested in Ophthotech. (12/15/09)
  Posted 12/15/09 at 10:00pm via fiercebiotech.com
• 
  HBM BioVentures invested in Probiodrug. (11/2/09)
  Posted 11/3/09 at 1:20am via probiodrug.de
• 
  HBM BioVentures invested in Kolltan Pharmaceuticals. (10/12/09)
  Posted 10/12/09 at 5:58pm via onbiovc.com
• 
  HBM BioVentures invested in MTM Laboratories. (10/5/09)
  Posted 1/22/10 at 4:20pm via mtmlabs.com
• 
  HBM BioVentures invested in Lux Biosciences. (10/1/09)
  Posted 10/19/09 at 5:47pm via venturebeat.com
• 
  HBM BioVentures invested in Zosano Pharma. (8/6/09)
  Posted 8/6/09 at 10:23am via onbiovc.com

Investments

Videos

Sources

1. PTC Therapeutics Completes $30M Financing (finsmes.com) [edit]
2. Probiodrug Raises €15M in Funding (finsmes.com) [edit]
3. Ellipse Technologies Closes $17.6M Series C Private Equity Financing (finsmes.com) [edit]
4. Delenex Therapeutics Raises $19.3M (finsmes.com) [edit]
5. Vivacta Closes £4M Financing Round (finsmes.com) [edit]
6. mtm laboratories Raises Additional €7M in Series C Financing (finsmes.com) [edit]
7. Cylene Pharmaceuticals Gets $12M (socaltech.com) [edit]
8. Nereus Pharmaceuticals, Inc.: Series E $20M (onbiovc.com) [edit]
9. Nabriva Therapeutics, AG: Series B $22M (onbiovc.com) [edit]
10. PTC Therapeutics Raises 50M in Equity Financing (finsmes.com) [edit]
11. Ophthotech nabs $30M round to fund AMD trial (fiercebiotech.com) [edit]
12. Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) (probiodrug.de) [edit]
13. Kolltan Pharmaceuticals, Inc.: Series A $5M (onbiovc.com) [edit]
14. mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million) (mtmlabs.com) [edit]
15. Lux Biosciences scores $50M Series B for eye cure (venturebeat.com) [edit]
16. Zosano Pharma, Inc.: Series B $30M (onbiovc.com) [edit]
17. ESBATech rounds up $22M in second round (fiercebiotech.com) [edit]
18. Pelikan Tech to push “finger friendly” diabetes testing (venturebeat.com) [edit]
19. Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com) [edit]
20. Sloning BioTechnology GmbH Raised € 4.7m in a First Closing of a Series E Equity Financing Round (sloning.com) [edit]
21. Adnexus Therapeutics Raises $15.5 Million in Series C Funding (adnexustx.com) [edit]
22. Agensys Raises $41 Million (agensys.com) [edit]
23. BaroFold pulls in $12M for protein-refolding technology (venturebeat.com) [edit]
24. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
25. Cylene Pharmaceuticals Closes $44 Million Series C Financing (rctech.com) [edit]
26. ChemoCentryx Completes Series C Financing (chemocentryx.com) [edit]
27. ESBATech Closes USD 41M Series B Venture Financing (esbatech.com) [edit]
28. GENIZON SECURES $12 MILLION IN SECURED CONVERTIBLE DEBENTURES (genizon.com) [edit]
29. PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING (ptct.client.shareholder.com) [edit]
30. Mpex Pharmaceuticals Closes $32 Million Series B Financing (mpexpharma.com) [edit]
31. Sloning BioTechnology closes new round of financing (sloning.com) [edit]
32. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]
33. History of mtm laboratories AG (mtmlabs.com) [edit]
34. Broncus Technologies lines up venture debt financing for emphysema treatment (venturebeat.com) [edit]